Oocytes were obtained from wild-type South African clawed frogs (Xenopus Express, Brooksville, FL) following a protocol approved by the Institutional Animal Care and Use Committee of UConn Health. Capped cRNA of lgc-46 was synthesized using a T3 mMessage mMachine Kit (Life Technologies, Carlsbad, CA, USA), and injected into defolliculated oocytes (∼50 nl per oocyte at 1.0 ng nl−1) using a Drummond Nanoject II injector (Drummond Scientific, Broomall, PA, USA). Two-electrode whole-cell recordings were performed 4–5 days after cRNA injection using an oocyte clamp amplifier (OC-725C, Warner Instruments, Hamden, CT, USA) and the Clampex software. The holding voltage was −60 mV. Data were filtered at 1 kHz and sampled at 10 kHz. In each experiment, a single oocyte was placed in an oocyte perfusion chamber (AutoMate Scientific, Berkeley, CA, USA) containing ND96 solution (compositions in mM: 96 NaCl, 2.0 KCl, 1.8 CaCl2, 1.0 MgCl2, 5.0 HEPES, pH 7.2). Candidate agonists were perfused into the oocyte perfusion chamber through a micro-manifold (AutoMate Scientific). An 8-channel perfusion controller (Valvelink8.2, AutoMate Scientific) was used for perfusion with its valves controlled by pClamp.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.